Background: A defective skin barrier is hypothesized to be an important route of
| INTRODUCTION
Cutaneous exposure to foods via a defective skin barrier is hypothesized as a route of sensitization to foods. Infants with early onset eczema are significantly more likely to develop food allergies 1 and in this context it has been proposed that disrupted skin barrier function in early life may facilitate sensitization to foods due to passage of food antigens across the impaired epicutaneous barrier. According to the "Dual Allergen Hypothesis" the timing and balance of cutaneous exposure relative to oral exposure can result in food allergy. 2, 3 Mutations in skin barrier integrity genes are therefore potential risk factors for the development childhood food allergy. In support of this, loss of function mutations in the epidermal gene encoding filaggrin (FLG) have been associated with risk of peanut sensitization 4 and peanut allergy. [5] [6] [7] Yet the role of other skin barrier genes in the development of food allergy is underexplored.
Another gene of relevance to skin barrier integrity is SPINK5.
SPINK5 encodes the protein product lymphoepithelial Kazal-typerelated inhibitor (LEKTI), a serine protease inhibitor. LEKTI is involved in the regulation of the desquamation process, that is the shedding of the outermost layer of the epidermis, by inhibiting serine proteases kallikrein (KLK) 5, KLK7 and KLK14. 8 Mutations in SPINK5 are associated with the rare recessive skin condition Netherton syndrome (NS), 9 a condition frequently co-associated with atopic manifestations, including food allergy. 10 Single nucleotide polymorphisms (SNPs) at SPINK5 have now been identified as associated with risk of asthma 10, 11 and eczema. 10, [12] [13] [14] [15] [16] However, the results have not always been consistent. 11, [17] [18] [19] To date no studies have directly examined the association of SPINK5 variants with challenge-proven food allergy, despite clear association of this gene with skin barrier integrity and atopic manifestations. A study of 115 Japanese children with atopic dermatitis (AD) reported that a SPINK5 SNP, rs2303067 [1258: G⟶A(Glu420Lys)], associated with severity of AD was also a risk factor for food allergy, 13 although this study was not able to assess the role of SPINK5 in food allergy risk independent of AD status. Here we sought to specifically investigate the relationship between SPINK5 SNPs and food allergy in a cohort of one-year-old infants with challenge-proven clinical outcomes. With replication in an independent sample, our data seeks to investigate whether SPINK5 variants are genetic risk factors for food allergy.
| METHODS

| Study populations
For the discovery analysis, DNA samples were obtained from the (Table S1 ).
For all studies eczema status was ascertained by history of doctordiagnosed eczema, or nurse observed eczema at presentation to clinic.
| Genotyping and quality control (QC)
Tag-SNPs across the SPINK5 region were chosen on the basis of linkage disequilibrium (LD), calculated using HapMap data in Haploview. Figure S1 . For the replication study, the top four SNPs associated with food allergy from the discovery analysis (rs9325072, rs3815741, rs4705054, rs9325071; Figure S3A ) above the nominal Pvalue (<.05) were selected for replication. After QC in the replication study there were 906 individuals genotyped for three SNPs (rs9325072, rs4705054, rs9325071; Figure S3B ). All individuals in the replication sample were genotyped using the AIM panel and ancestry was genetically inferred (see Figure S4 ), described in the Data S1.
| Transepidermal water loss measures
Measures of transepidermal water loss (TEWL) were available for a subset of HN participants with SPINK5 genotype data (n=150). Participants were given time to acclimatize to the clinic room (20 minutes); during this time, clothing was removed from the testing site.
Atmospheric temperature and humidity were recorded, as well as skin temperature. Atmospheric temperature was on average 24°C
(min: 20.8°C; max: 27°C). TEWL measures were recorded using the Tewameter â TM300 at the mid-lower back until five consecutive measures within standard deviation of ≤.2 were achieved. Raw TEWL (g/m 2 h) readings were positively skewed and therefore logtransformed prior to analysis.
| Data analysis
Ancestry strata were ascertained indirectly by parental country of birth in the HN study and samples were classified as Caucasian (both parents born in Australia, Europe, the UK, Northern America or New Zealand, n=503), Asian (both parents born in South-East Asia, n=74)
or mixed Asian-Caucasian (n=145). We used genomewide SNP data, available on a subset (n=344) of the discovery sample, and identityby-state clustering analysis against the human reference populations 31 to establish the accuracy of our predicted ancestry strata to assess the accuracy of our parent country of birth as proxy measure of ancestry ( Figure S5 ). The strata we defined based on parental country of birth were highly correlated with genetically determined ancestry (93.7% correlation for "Caucasians" and 93.0% correlation for "Asians") ( Figure S5 ). All analyses of the discovery study were modelled using Cochran-Mantel-Haenszel tests adjusting for sex and ancestry strata in PLINK, and the genomic inflation factor was 1.10, indicating only modest inflation. 32 The primary analysis of the discovery cohort tested the association between SPINK5 SNPs and food-allergic cases and non-foodallergic controls. A secondary analysis was conducted in the discovery cohort to tease apart the relationship between the variants and clinically reactive (challenge-proven food allergy) or asymptomatic (sensitized-tolerant) food allergy using the same analysis model. An additional secondary analysis was conducted to measure allele frequencies between food-allergic cases and food-sensitized-tolerant cases, to test whether there was evidence for a stronger association amongst the clinically distinct outcomes. Further, to test whether the observed genetic associations for food allergy were driven by comorbid eczema, an additional analysis for an association with challengeproven food allergy was conducted excluding infants with eczema.
In the replication phase principal components (PC) from the AIMs data were used to adjust for heterogeneity arising from population structure. Genetically inferred ancestry determined 657 individuals to be of European descent, 217 of mixed European-Asian descent and 32 of Asian descent. Logistic regression, adjusted for PCs, sex and study in PLINK was used to test for differences in minor allele frequencies between food-allergic and non-food-allergic individuals of the replication sample. Finally, due to differences in phenotype criteria used amongst these studies, a sensitivity analysis was conducted restricting to phenotype and age matched cases and controls (the BIS). BIS utilized OFC to define case-control status at 12 months of age, consistent with measures used in the discovery analysis. SimpleM, 33 a method of correction for multiple testing of correlated SNPs, was used to define multiple-testing-adjusted P-value thresholds for the discovery and replication. SimpleM is a PC analysis approach which captures the correlation of SNPs in the data set and calculates the number of independent tests M eff . Inferred M eff in the discovery was 47, the derived significance threshold was therefore calculated with the formula 0.05/M eff . This formula gave the corrected significance threshold of 0.001. For replication the calculated M eff was 7, giving a derived significance threshold of 0.007.
Meta-analysis of the discovery and replication panels was performed using the PLINK meta-analysis function for food allergy (n=570) vs nonallergic controls (n=486) using the association files from the discovery Cochran-Mantel-Haenszel test and the replication logistic regression adjusted for ancestry PC.
For the TEWL analysis associations between log(TEWL g/m 2 h) and each variant were analysed using linear regression to assess whether there was a difference in measurable skin barrier functionality in those with the risk variant (n=150). TEWL recordings were analysed by genotype of SNPs associated with food allergy.
3 | RESULTS
| Characteristics of the study participants
Overall 722 infants, 367 food-allergic, 199 food-sensitized-tolerant and 156 nonallergic controls were included in the discovery analysis (Table 1 ). The proportion of clinically allergic children in this population was 50% whilst the rate of food sensitization was 78%. Egg allergy was the most common type of food allergy at 89.3%, followed by peanut 32.2% and sesame 6.7%. Amongst the food-allergic group, 56.4% had concurrent atopic eczema, which was higher when compared with the food-sensitized group (37.7%) or nonallergic controls (25.0%).
| SPINK5 variants associated with food allergy
When comparing challenge-proven food allergy cases with nonallergic controls in the individuals of the discovery study we identified a haplotype block of correlated SNPs ( Figure S3) To test whether these genetic associations were being driven by comorbid eczema the analysis was then repeated in infants without eczema (leaving n=174 food-allergic cases and n=90 non-food-allergic controls). The top associations remained consistent, illustrating that the association is with food allergy and not eczema and that eczema is not involved in the mechanism for this association (Table S2) .
A secondary analysis of food-sensitized-tolerant (ie asymptomatic food allergy) compared to non-food-allergic controls was conducted.
One SNP associated with challenge-proven food allergy showed a significant (nominal P<.05) association with the food-sensitized-tolerant phenotype (rs9325072 P=.04, OR=2.11, CI=1.01-4.41) (Table 2B) .
T (Table 2C ).
| Replication of candidate risk variants
Comparing food-allergic cases to non-food-allergic controls in the replication sample, only one association (rs9325071, fourth most significant association in the discovery sample) remained consistent with the discovery (P=.007, OR=1.58, CI=1.13-2.20) (Table 3A) and reached the derived multiple-testing-corrected significance threshold.
Again this association remained after infants with eczema were removed to ascertain if the association was driven by comorbid eczema. In the sensitivity analysis restricted to only infants with OFC outcomes, the direction of effect was similar but 95% CIs included 1 (rs9325071: OR=1.40, CI=0.66-2.93).
In a meta-analysis of data from discovery and replication (n=1056), A1 is the minor allele, OR is the odds ratio, L95 and U95 are the lower and upper limits to the 95% confidence interval and P column indicates the Pvalue for the association. A: 367 food-allergic cases vs 156 non-food-allergic controls. B: 199 food-sensitized-tolerant cases vs 156 non-food-allergic controls. C: 367 food-allergic cases vs 199 food-sensitized-tolerant cases.
T A B L E 3 (A) Associations between SPINK5 SNPs and food allergy in replication sample adjusted for ancestry using principal components.
(B) Meta-analysis of discovery and replication associations between SPINK5 SNPs and food allergy A: Replication analysis adjusted for gender, ancestry (by principal components) and study. B: Meta-analysis P(R) is the P-value estimate deriving from the random-effects meta-analysis model, and OR(R) is likewise the odds ratio estimate derived from the random-effects model. Q is the P-value from Cochran's Q statistic of effect size heterogeneity between studies, and I is the I 2 heterogeneity index (0-100).
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| 1361 further supported (see Table 3B ). There was strong evidence against a null hypothesis of homogeneity across studies (the discovery and the replication samples) of the magnitude of the association (effect size), as detected by Cochran's Q statistic, between variant rs9325072 and rs4705054 and the risk of food allergy (see Table 3B ).
| Evidence of skin barrier impairment via transepidermal water loss measurement
The analysis of transepidermal water loss (TEWL) provided some preliminary evidence that there may be a recessive effect on skin barrier permeability by genotype for food allergy-associated SNPs (Table S3 ). However, the number of individuals with both minor allele genotypes and TEWL data in this analysis was underpowered to conclude anything more than a suggestive result that warrants further exploration.
| Expression of qualitative trait loci (eQTL)
To further explore function of the replicated food allergy-associated variant, publicly available gene expression data by tissue type was accessed from the GTEx Project database. Replicated variant rs9325071 was significantly associated with decreased SPINK5 expression in the skin (P=8. 9910 6 ) in the GTEx database, suggesting the variant is a functional expression of qualitative trait loci.
| DISCUSSION
In this study we report a novel genetic association between SPINK5
variants and IgE-mediated food allergy. This is the first time these variants have been examined in the context of challenge-proven food allergy, the genetic mechanisms of which are still largely unknown.
This study adds to a growing list of candidate gene associations and provides the foundation for extensive testing in other populations.
We focused on SPINK5 with a prior expectation that this gene may harbour variants associated with food allergy due its critical role in skin barrier integrity and its co-association with atopic food allergy in patients with Netherton syndrome. The integrity of the skin barrier is increasingly recognized as a critical protective factor against IgE-mediated food allergy.
Using a tag-SNP approach provided broad genotype coverage of common variants in SPINK5 and revealed SNPs in a haplotype block to be associated with clinical food allergy. The high level of correlation between these variants suggests they are frequently co-inherited and future fine mapping studies are now needed to resolve the specific causal variants.
Within this haplotype block, SNP rs9325071 was shown to be associated with food allergy in both the discovery and replication sample. Analysis of publicly available gene expression data revealed rs9325071 G allele carriage to be associated with decreased SPINK5 expression in the skin, suggesting a plausible functional role for this variant in skin barrier integrity. Additionally, individuals in this study who were homozygous for the rs9325071 minor allele exhibited higher levels of TEWL. Whilst these data lend further support for a functional impact of rs9325071 on skin barrier integrity, our sample size was small, and thus, the findings need to be considered cautiously. We can reasonably conclude that the overall trend may suggest a potential functional role for this SNP by way of reduced LEKTI expression (the product of SPINK5) and increased skin permeability. Skin barrier impairment may allow for increased allergen absorption across the skin, and when this precedes oral allergen ingestion, which is largely tolerogenic, 34 food sensitization may develop. 35 A similar pathway has been proposed for household peanut exposure in infants with FLG LOF mutations. 5 This is further supported by observations in a murine model of skin barrier impairment induced by tape stripping, stimulating thymic stromal lymphopoietin (TSLP) production. 36 These mice subsequently became sensitized to the locally applied allergen, with detectable systemic allergen specific immune responses. 36 An alternative mechanism of action might occur via impaired LEKTI signalling and TSLP expression. LEKTI-deficient keratinocytes produce uninhibited KLK5, perpetuating pro-allergic Th2 signalling, including elevated TSLP expression. 37 LEKTI expression in the thymus has also been hypoth- A strength of this study was our ability to explore whether SPINK5 variants were associated with the risk for developing food sensitization, or clinical food allergy, due to the availability of challenge-proven phenotypic groups in the discovery sample. The replicated food allergy-associated SNP, rs9325071, was associated with clinical food allergy (P=.02, OR=1.83, CI=1.11-3.03) in the discovery analysis but was not associated with asymptomatic food sensitization (P=.26, OR=1.38, CI=0.79-2.41), suggesting it may predispose to a more severe clinical phenotype. However, the sample size available for the sensitized group was smaller than that for the allergic group, and this may have limited our power to detect association with sensitization. Larger studies would be required to confirm this finding.
An important finding from this study was that SPINK5 variation increases the risk of clinical food allergy independently of eczema.
This was an important mechanism to consider given food allergy and eczema are frequent comorbidities, and previous studies have reported SPINK5 variants associated with maternal transmission of AD. 10 It is likely that SPINK5 polymorphisms are a risk factor for both food allergy and atopic eczema.
A limitation of the study is the sample size of the discovery cohort which did not allow for robust associations after multipletesting correction. Thus, we relied heavily on a replication sample, which showed the strongest associations in the discovery cohort to be false positives. Further strengths of this study include the highly clinically relevant case definitions, the replication in an independent population, and the inclusion of functional data. A limitation of this study was the potential heterogeneity between the discovery and the replication samples in terms of age and phenotype definitions.
To address this we provided a supportive sensitivity analysis in infants with outcomes defined only by OFC, to remain consistent with the discovery study. The effect size estimates resulting from this replication subanalysis were consistent with the effect size estimates for the overall replication sample, providing evidence that heterogeneity arising from differences in outcome definitions was not introducing confounding. Another limitation was the use of parental country of birth as a proxy measure of ancestry rather than genetically determined ancestry in the discovery population. To address this parental country of birth was compared to available genomewide SNP data on a subset of the discovery sample, providing evidence that parental country of birth clustered well with genetically inferred ancestry. A final potential limitation is that OFCs were not double-blinded placebo controlled. However, as published in the PRACTALL guidelines, at 12 months of age infants are unlikely to have false-positive results due to subjective symptoms. 22 In conclusion, with replication in two populations we present cogent evidence that SPINK5 variants are associated with clinical food allergy in children.
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